The pace of climate change has increased worldwide in the past decade.1 Europe is the fastest-heating continent, with temperatures increasing at more than twice the global average rate since the ...
On May 2, 2026, a cluster of severe respiratory illness among passengers aboard a cruise ship in the Atlantic was reported to WHO, and a suspected hantavirus outbreak was identified. The vessel ...
Autologous stem-cell transplantation (ASCT) has remained central to the care of younger patients with mantle cell lymphoma since the publication of the first European Mantle Cell Lymphoma Network ...
Vaccines remain one of the most impactful and cost-effective public health interventions. Decades of evidence from randomised controlled trials and epidemiological studies have shown the impact of ...
Marcello Ienca and colleagues1 in their Review identify a trust paradox in which rigorous institutions lose credibility while unaccountable voices gain it. We argue that large language model ...
Peru is expanding access to surgery and care for patients with cleft conditions in remote areas through intensive ...
Scientific literature depends on the integrity of its references. Each reference implicitly asserts that a verifiable source ...
WHO's approval of the RTS,S/AS01 (Mosquirix) malaria vaccine in 2021 marked a milestone in global public health. It ...
We read with interest the letter by Kwok Chiu Chang and appreciate the potential implications they raise for individuals in settings in which rapid, reliable, and complete drug susceptibility testing ...
The Lancet published an Editorial on reviving research into psychedelics for mental health conditions, observing that “the ...
Opinion
Is ATLAS lifting the burden of stroke in people with large-vessel occlusion and low ASPECTS scores?
In Greek mythology, Atlas is the powerful Titan condemned by Zeus to eternally bear the celestial spheres—a profound symbol of endurance and strength. These very virtues are necessitated in patients ...
With very low certainty of evidence, WHO has conditionally recommended two 6-month or 9-month regimens for pre-extensively drug-resistant (pre-XDR) tuberculosis: one comprising bedaquiline, pretomanid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results